ASAM Pocket Guidelines and Patient Guide

ASAM Opioid Use Disorder Patient Guide 2025

ASAM Opioid Addiction Treatment GUIDELINES Apps and Pocket Guides brought to you courtesy of Guideline Central. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1536453

Contents of this Issue

Navigation

Page 10 of 23

11 Naltrexone • Naltrexone works by blocking opioids from acting on the brain. This means that the patient won't get high from using opioids while taking naltrexone. Naltrexone is a good option for preventing relapse in patients who are no longer dependent on opioids. • Patients cannot have any opioids in their body when starting naltrexone. If they do, it will quickly cause severe withdrawal. Before a clinician starts a patient with an active opioid addiction on naltrexone, the patient must go through withdrawal under the clinician's supervision. This period typically lasts 6–10 days. • Naltrexone is given in an extended release form that is injected in the buttocks. The injection is administered by the clinician in the office once every 3–4 weeks. • Naltrexone is also available as a pill, but this form is NOT recommended when treating opioid addiction, except under very limited circumstances. • Many patients will need to continue taking naltrexone for an extended period of time. Because naltrexone does not produce physical dependence, it can be stopped abruptly without withdrawal symptoms. However, stopping naltrexone can put the patient at risk for relapse and overdose. This should only be done with careful monitoring by the clinician.

Articles in this issue

view archives of ASAM Pocket Guidelines and Patient Guide - ASAM Opioid Use Disorder Patient Guide 2025